Trial Identifier: | D1346C00004 |
Sponsor: | AstraZeneca |
Collaborator: |
Merck Sharp & Dohme Corp.
|
NCTID:: | NCT05309668 |
Start Date: | January 2022 |
Primary Completion Date: | January 2024 |
Study Completion Date: | October 2027 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
No documents have been posted yet.
Country | Location |
---|---|
Germany | Berlin, Germany, 13353 |
Germany | Hamburg, Germany, 20246 |
Germany | Munchen, Germany, 80337 |
Germany | Tubingen, Germany, 72076 |
Italy | Milano, Italy, 20133 |
Italy | Roma, Italy, 00165 |
Italy | Torino, Italy, 10126 |
Japan | Nagoya-shi, Japan, 466-8560 |
Japan | Setagaya-ku, Japan, 157-8535 |
Japan | Yufu-shi, Japan, 879-5593 |
Netherlands | Rotterdam, Netherlands, 3015 GD |
Russia | Moscow, Russia, 125412 |
Russia | Moscow, Russia, 119620 |
Spain | Barcelona, Spain, 08950 |
USA, AZ | Phoenix, AZ, USA, 85060 |
USA, IN | Indianapolis, IN, USA, 46202 |
USA, OH | Akron, OH, USA, 44308 |
USA, PA | Philadelphia, PA, USA, 19104 |
USA, TX | Houston, TX, USA, 77030 |
USA, VA | Richmond, VA, USA, 23219 |